Antisense Oligonucleotide [EPC]

Antisense Oligonucleotide [EPC] was reported 11948 times

Drugs of the Antisense Oligonucleotide [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NEUROMUSCULAR SCOLIOSIS 9 0.5294
1 TRAUMATIC LUMBAR PUNCTURE 26 0.5098
2 POST LUMBAR PUNCTURE SYNDROME 524 0.5038
3 SPINAL MUSCULAR ATROPHY 107 0.3963
4 CEREBROSPINAL FLUID RESERVOIR PLACEMENT 6 0.3750
5 NEUROLOGICAL PROCEDURAL COMPLICATION 27 0.2045
6 MUSCULOSKELETAL PROCEDURAL COMPLICATION 12 0.1818
7 RESPIRATORY TRACT PROCEDURAL COMPLICATION 8 0.1481
8 CSF RED BLOOD CELL COUNT POSITIVE 4 0.1143
9 CYSTATIN C INCREASED 14 0.1094
10 EXERTIONAL HEADACHE 7 0.1094
11 CSF PRESSURE INCREASED 23 0.0865
12 PROCEDURAL VOMITING 48 0.0738
13 MECHANICAL VENTILATION COMPLICATION 11 0.0738
14 CATHETER SITE SCAR 4 0.0667
15 PROCEDURAL NAUSEA 45 0.0559
16 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 4 0.0556
17 POST PROCEDURAL FEVER 13 0.0539
18 TRACHEOSTOMY MALFUNCTION 11 0.0531
19 PROCEDURAL HEADACHE 21 0.0512
20 ACQUIRED ATTR AMYLOIDOSIS 2 0.0488
21 SPINAL ROD INSERTION 5 0.0467
22 PROCEDURAL ANXIETY 30 0.0442
23 ANAESTHETIC COMPLICATION CARDIAC 3 0.0435
24 CEREBROSPINAL FLUID LEAKAGE 79 0.0427
25 SCOLIOSIS SURGERY 3 0.0417
26 SCOLIOSIS 248 0.0400
27 DURAL TEAR 3 0.0385
28 EXPOSURE TO SARS-COV-2 65 0.0382
29 POOR VENOUS ACCESS 389 0.0376
30 MENINGITIS CHEMICAL 8 0.0364
31 POST PROCEDURAL CONTUSION 11 0.0335
32 ENTEROVIRUS INFECTION 28 0.0324
33 VITAMIN A DECREASED 5 0.0323
34 DUCHENNE MUSCULAR DYSTROPHY 3 0.0323
35 PROCEDURAL DIZZINESS 10 0.0310
36 RHINOVIRUS INFECTION 110 0.0282
37 MENINGITIS STAPHYLOCOCCAL 4 0.0282
38 CATHETER SITE SCAB 3 0.0280
39 NEUROLOGICAL EXAMINATION ABNORMAL 13 0.0278
40 CATHETER SITE OEDEMA 3 0.0275
41 CSF GLUCOSE DECREASED 3 0.0259
42 PATIENT UNCOOPERATIVE 12 0.0253
43 PROTEIN URINE PRESENT 126 0.0253
44 CSF VOLUME INCREASED 3 0.0252
45 CREATININE URINE ABNORMAL 3 0.0242
46 PHYSICAL EXAMINATION ABNORMAL 9 0.0235
47 NASAL SEPTUM DISORDER 6 0.0226
48 VIRAL SEPSIS 3 0.0214
49 HUMAN BOCAVIRUS INFECTION 4 0.0212
50 CSF WHITE BLOOD CELL COUNT INCREASED 4 0.0209
51 TESTICULAR TORSION 3 0.0207
52 BRONCHIAL SECRETION RETENTION 26 0.0204
53 CHRONIC RESPIRATORY FAILURE 22 0.0182
54 URINARY RETENTION POSTOPERATIVE 3 0.0182
55 CATHETER SITE SWELLING 17 0.0182
56 CATHETER SITE BRUISE 6 0.0181
57 CSF PROTEIN INCREASED 15 0.0181
58 PNEUMONIA PARAINFLUENZAE VIRAL 3 0.0176
59 CATHETER SITE EXTRAVASATION 7 0.0175
60 PROCEDURAL FAILURE 3 0.0169
61 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 14 0.0166
62 DEFORMITY THORAX 3 0.0155
63 CATHETER SITE PAIN 40 0.0154
64 KYPHOSCOLIOSIS 4 0.0152
65 MENINGISM 7 0.0149
66 LORDOSIS 5 0.0142
67 RESPIRATORY TRACT INFECTION VIRAL 33 0.0142
68 PROCEDURAL PAIN 392 0.0141
69 INTENTIONAL DOSE OMISSION 399 0.0140
70 INTRACRANIAL HYPOTENSION 9 0.0138
71 METAPNEUMOVIRUS INFECTION 10 0.0128
72 RESPIRATORY MUSCLE WEAKNESS 4 0.0123
73 SUDDEN INFANT DEATH SYNDROME 6 0.0122
74 DEVELOPMENTAL HIP DYSPLASIA 10 0.0120
75 CATHETER SITE IRRITATION 4 0.0120
76 MENINGITIS BACTERIAL 17 0.0119
77 AIRWAY COMPLICATION OF ANAESTHESIA 3 0.0114
78 TRACHEAL HAEMORRHAGE 4 0.0114
79 GASTROINTESTINAL PROCEDURAL COMPLICATION 3 0.0112
80 PARAINFLUENZAE VIRUS INFECTION 17 0.0112
81 INCREASED BRONCHIAL SECRETION 28 0.0109
82 RESPIRATORY SYNCYTIAL VIRUS INFECTION 95 0.0109
83 BULBAR PALSY 3 0.0108
84 ACUTE PHASE REACTION 4 0.0105
85 PLEOCYTOSIS 6 0.0103
86 JOINT CONTRACTURE 11 0.0103
87 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 8 0.0102
88 ARACHNOID CYST 4 0.0102
89 ARACHNOIDITIS 7 0.0101
90 SPINAL CORD HAEMORRHAGE 4 0.0100
91 CSF TEST ABNORMAL 5 0.0099
92 CATHETER SITE RELATED REACTION 7 0.0093
93 RED BLOOD CELL SCHISTOCYTES PRESENT 3 0.0093
94 TRACHEITIS 7 0.0092
95 HIP DEFORMITY 4 0.0092
96 INFUSION SITE SCAR 4 0.0090
97 TROPONIN I INCREASED 15 0.0090
98 SPINAL DEFORMITY 15 0.0089
99 INTRACRANIAL PRESSURE INCREASED 49 0.0088
100 MOTOR DYSFUNCTION 89 0.0087
101 ADMINISTRATION SITE BRUISE 3 0.0086
102 FAT EMBOLISM 3 0.0085
103 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 2 0.0081
104 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
105 VEIN RUPTURE 13 0.0078
106 HEMIPARAESTHESIA 3 0.0077
107 FORCED VITAL CAPACITY DECREASED 5 0.0077
108 PROCEDURAL SITE REACTION 4 0.0076
109 COCCYDYNIA 11 0.0075
110 MUSCLE CONTRACTURE 15 0.0074
111 CENTRAL VENOUS CATHETERISATION 22 0.0073
112 ANAESTHETIC COMPLICATION 19 0.0071
113 VERTEBRAL OSTEOPHYTE 3 0.0070
114 MOTOR DEVELOPMENTAL DELAY 4 0.0069
115 BACTERIAL DISEASE CARRIER 5 0.0069
116 PNEUMONIA INFLUENZAL 8 0.0067
117 URINARY TRACT INFECTION PSEUDOMONAL 4 0.0067
118 CATHETER SITE RASH 3 0.0066
119 PNEUMONIA VIRAL 21 0.0066
120 SACRAL PAIN 4 0.0066
121 PRODUCT DISTRIBUTION ISSUE 61 0.0066
122 NEEDLE FATIGUE 3 0.0066
123 POST PROCEDURAL INFLAMMATION 4 0.0065
124 MEDICAL DEVICE SITE INFECTION 4 0.0064
125 POST PROCEDURAL SWELLING 7 0.0064
126 TRACHEOSTOMY 9 0.0063
127 PNEUMONIA MYCOPLASMAL 5 0.0063
128 HAND-FOOT-AND-MOUTH DISEASE 5 0.0060
129 ALLERGIC RESPIRATORY SYMPTOM 2 0.0060
130 SARS-COV-2 TEST POSITIVE 79 0.0060
131 BRAIN HYPOXIA 6 0.0060
132 GASTROSTOMY 9 0.0058
133 ASPIRATION 62 0.0057
134 PRODUCT TEMPERATURE EXCURSION ISSUE 29 0.0056
135 UNDERWEIGHT 11 0.0056
136 EPHELIDES 3 0.0056
137 PROCEDURAL COMPLICATION 42 0.0055
138 POST PROCEDURAL HAEMATOMA 9 0.0053
139 ADENOIDAL HYPERTROPHY 2 0.0053
140 PROTEIN TOTAL INCREASED 14 0.0053
141 CEREBRAL VENTRICLE DILATATION 6 0.0052
142 CREATINE KINASE INCREASED 4 0.0052
143 ATELECTASIS 50 0.0052
144 ADENOVIRUS INFECTION 15 0.0052
145 INFUSION SITE EXTRAVASATION 32 0.0051
146 CATHETER SITE ERYTHEMA 11 0.0051
147 MYCOPLASMA INFECTION 4 0.0051
148 BLOOD CREATININE DECREASED 16 0.0051
149 RESPIRATORY TRACT INFECTION 128 0.0049
150 RESPIRATORY DISORDER 147 0.0049
151 VACCINATION COMPLICATION 4 0.0049
152 POST PROCEDURAL DISCOMFORT 10 0.0048
153 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2 0.0048
154 TONSILLAR HYPERTROPHY 8 0.0048
155 TIBIA FRACTURE 22 0.0047
156 DEAFNESS TRANSITORY 4 0.0047
157 VIRAL UPPER RESPIRATORY TRACT INFECTION 22 0.0046
158 FOOD REFUSAL 4 0.0046
159 NO ADVERSE EVENT 825 0.0045
160 BRONCHIOLITIS 16 0.0045
161 BRONCHITIS VIRAL 3 0.0045
162 MENINGITIS ASEPTIC 20 0.0045
163 ACUTE RESPIRATORY FAILURE 83 0.0043
164 URINE LEUKOCYTE ESTERASE POSITIVE 3 0.0043
165 PATELLA FRACTURE 10 0.0043
166 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0042
167 HYDROCEPHALUS 23 0.0042
168 FOREIGN BODY ASPIRATION 3 0.0041
169 APALLIC SYNDROME 3 0.0041
170 CYCLIC VOMITING SYNDROME 3 0.0041
171 FEBRILE CONVULSION 5 0.0041
172 THERAPEUTIC RESPONSE SHORTENED 136 0.0041
173 KYPHOSIS 7 0.0040
174 TROPONIN T INCREASED 5 0.0039
175 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 3 0.0039
176 PNEUMONIA PSEUDOMONAL 6 0.0039
177 RESPIRATORY SYMPTOM 11 0.0039
178 TALIPES 12 0.0039
179 INFUSION SITE DISCOMFORT 4 0.0039
180 PRODUCT DOSE OMISSION ISSUE 1133 0.0038
181 CROUP INFECTIOUS 3 0.0038
182 URETEROLITHIASIS 4 0.0038
183 PNEUMOTHORAX 60 0.0038
184 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 19 0.0037
185 HAPTOGLOBIN DECREASED 3 0.0037
186 GLYCOSURIA 5 0.0037
187 PSEUDOMONAS TEST POSITIVE 3 0.0037
188 SCIATIC NERVE INJURY 3 0.0036
189 CRYPTORCHISM 4 0.0036
190 CEREBRAL VENOUS SINUS THROMBOSIS 3 0.0036
191 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
192 SEDATION COMPLICATION 9 0.0035
193 DEVICE ISSUE 316 0.0035
194 INVESTIGATION ABNORMAL 5 0.0035
195 MENINGITIS 23 0.0034
196 POST PROCEDURAL COMPLICATION 66 0.0034
197 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
198 RESTRICTIVE PULMONARY DISEASE 4 0.0034
199 AMBLYOPIA 2 0.0034
200 NEPHROCALCINOSIS 4 0.0034
201 SKIN STRIAE 5 0.0034
202 GASTROINTESTINAL INFECTION 30 0.0033
203 URINE ANALYSIS ABNORMAL 10 0.0033
204 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
205 PROTEIN URINE 3 0.0033
206 GRANULOCYTE COUNT DECREASED 6 0.0032
207 NOSOCOMIAL INFECTION 7 0.0032
208 FRACTURED COCCYX 4 0.0032
209 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 4 0.0031
210 FIBULA FRACTURE 9 0.0031
211 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9 0.0031
212 FEMUR FRACTURE 95 0.0031
213 SECRETION DISCHARGE 38 0.0030
214 VIRAL INFECTION 99 0.0030
215 SPINAL FUSION SURGERY 12 0.0030
216 DEVICE DEPOSIT ISSUE 6 0.0029
217 GASTROINTESTINAL VIRAL INFECTION 3 0.0029
218 LOSS OF THERAPEUTIC RESPONSE 9 0.0028
219 INFUSION SITE BRUISING 6 0.0028
220 KETOSIS 3 0.0028
221 RESPIRATORY DISTRESS 76 0.0028
222 PULMONARY SEPSIS 4 0.0027
223 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
224 JOINT DISLOCATION 29 0.0027
225 PNEUMONIA STREPTOCOCCAL 3 0.0027
226 AUTISM SPECTRUM DISORDER 15 0.0027
227 PNEUMONIA ASPIRATION 68 0.0027
228 BACTERIAL TEST POSITIVE 6 0.0027
229 CATHETER SITE DISCHARGE 3 0.0027
230 WHITE BLOOD CELLS URINE POSITIVE 5 0.0027
231 LOWER LIMB FRACTURE 51 0.0027
232 LOSS OF CONTROL OF LEGS 10 0.0026
233 ADMINISTRATION SITE PAIN 3 0.0026
234 MALNUTRITION 29 0.0026
235 NEURITIS 4 0.0026
236 PHARYNGITIS STREPTOCOCCAL 28 0.0026
237 DECUBITUS ULCER 21 0.0026
238 PSEUDOMONAS INFECTION 22 0.0026
239 RECTAL ULCER 3 0.0026
240 PROCEDURAL HAEMORRHAGE 10 0.0026
241 GASTROENTERITIS 37 0.0025
242 GASTROENTERITIS VIRAL 45 0.0025
243 CUSHINGOID 8 0.0025
244 HAEMATOLOGICAL INFECTION 6 0.0025
245 VASCULAR DEVICE INFECTION 11 0.0024
246 BRAIN INJURY 24 0.0024
247 CATHETER SITE INFECTION 9 0.0024
248 FAECALOMA 13 0.0024
249 SEROMA 3 0.0024
250 SEIZURE LIKE PHENOMENA 4 0.0024
251 DEVICE OCCLUSION 33 0.0023
252 POST PROCEDURAL INFECTION 19 0.0023
253 HYPOTONIA 23 0.0023
254 RESPIRATORY ARREST 63 0.0023
255 INFECTION SUSCEPTIBILITY INCREASED 5 0.0023
256 ACUTE CHEST SYNDROME 2 0.0023
257 RADICULOPATHY 6 0.0023
258 MIDDLE EAR EFFUSION 5 0.0023
259 PAPILLOEDEMA 10 0.0022
260 STENOTROPHOMONAS INFECTION 3 0.0022
261 ANAESTHETIC COMPLICATION NEUROLOGICAL 2 0.0022
262 MIGRAINE WITH AURA 6 0.0022
263 CARBON DIOXIDE INCREASED 3 0.0022
264 RESPIRATORY FAILURE 160 0.0022
265 INFUSION SITE RASH 3 0.0022
266 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
267 H1N1 INFLUENZA 3 0.0021
268 INFLUENZA 237 0.0021
269 BLOOD ELECTROLYTES DECREASED 3 0.0021
270 MECHANICAL VENTILATION 4 0.0021
271 CARDIO-RESPIRATORY ARREST 87 0.0021
272 PULMONARY FUNCTION TEST DECREASED 9 0.0021
273 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
274 DEVICE INFUSION ISSUE 5 0.0020
275 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
276 FLUID INTAKE REDUCED 10 0.0020
277 PROTEINURIA 38 0.0020
278 PNEUMONIA BACTERIAL 18 0.0020
279 BRAIN DEATH 6 0.0019
280 COAGULATION TIME PROLONGED 3 0.0019
281 PRODUCT COMMUNICATION ISSUE 17 0.0019
282 NEPHROLITHIASIS 88 0.0019
283 URINE KETONE BODY PRESENT 3 0.0019
284 MUSCLE FATIGUE 8 0.0019
285 WEIGHT BEARING DIFFICULTY 5 0.0019
286 SPUTUM INCREASED 4 0.0018
287 OPTIC ATROPHY 3 0.0018
288 SHOULDER FRACTURE 3 0.0018
289 RENAL TUBULAR ACIDOSIS 4 0.0018
290 LIGAMENT SPRAIN 18 0.0018
291 DEVICE RELATED INFECTION 28 0.0018
292 INJECTION RELATED REACTION 3 0.0018
293 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
294 NEURALGIA 44 0.0018
295 POST PROCEDURAL HAEMORRHAGE 21 0.0018
296 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
297 APNOEA 14 0.0018
298 OXYGEN SATURATION DECREASED 101 0.0018
299 IDIOPATHIC INTRACRANIAL HYPERTENSION 4 0.0018
300 COVID-19 PNEUMONIA 21 0.0018
301 WOUND DEHISCENCE 6 0.0018
302 REGURGITATION 6 0.0017
303 AMYLOIDOSIS 3 0.0017
304 RENAL FUNCTION TEST ABNORMAL 8 0.0017
305 PSEUDOMONAL SEPSIS 3 0.0017
306 UPPER RESPIRATORY TRACT INFECTION 79 0.0017
307 SKIN HYPOPIGMENTATION 3 0.0017
308 PYREXIA 586 0.0017
309 SPINAL DISORDER 16 0.0017
310 PROTHROMBIN TIME PROLONGED 10 0.0017
311 BEHAVIOUR DISORDER 9 0.0017
312 HUMERUS FRACTURE 8 0.0017
313 MONOCYTE COUNT INCREASED 6 0.0017
314 MASTICATION DISORDER 5 0.0016
315 ATROPHY 3 0.0015
316 SUSPECTED COVID-19 5 0.0015
317 OTITIS MEDIA 5 0.0015
318 SUDDEN DEATH 16 0.0015
319 CEREBRAL ATROPHY 6 0.0015
320 BLOOD POTASSIUM ABNORMAL 4 0.0015
321 FUNGAL SKIN INFECTION 6 0.0015
322 COVID-19 258 0.0015
323 SUBDURAL HAEMORRHAGE 4 0.0015
324 RED BLOOD CELL COUNT INCREASED 4 0.0014
325 IMPAIRED SELF-CARE 3 0.0014
326 INFUSION SITE SWELLING 9 0.0014
327 PNEUMONIA 463 0.0014
328 MUSCULAR WEAKNESS 162 0.0014
329 DEVICE CONNECTION ISSUE 3 0.0014
330 EMBOLIC STROKE 5 0.0014
331 BREATH SOUNDS ABNORMAL 7 0.0014
332 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
333 HAEMORRHAGE SUBCUTANEOUS 5 0.0014
334 SCAR 24 0.0014
335 APPENDICITIS 13 0.0014
336 ACCIDENTAL UNDERDOSE 20 0.0014
337 ASPHYXIA 11 0.0013
338 MUSCULOSKELETAL DISORDER 25 0.0013
339 INSURANCE ISSUE 20 0.0013
340 CHOKING 25 0.0013
341 PRODUCT SUPPLY ISSUE 9 0.0013
342 NERVE INJURY 14 0.0013
343 STREPTOCOCCAL INFECTION 7 0.0013
344 ACCIDENT 15 0.0013
345 CARDIAC ARREST 103 0.0012
346 PULSE ABNORMAL 3 0.0012
347 COMPLICATION ASSOCIATED WITH DEVICE 18 0.0012
348 PRODUCT PACKAGING CONFUSION 3 0.0012
349 ANKLE FRACTURE 19 0.0012
350 PRODUCT PREPARATION ISSUE 8 0.0012
351 CYANOSIS 19 0.0012
352 PRESCRIBED UNDERDOSE 24 0.0012
353 SALIVARY HYPERSECRETION 12 0.0012
354 BACK PAIN 278 0.0012
355 SCIATICA 19 0.0012
356 BRONCHOSPASM 17 0.0012
357 ENERGY INCREASED 7 0.0012
358 TROPONIN INCREASED 9 0.0012
359 BACTERAEMIA 14 0.0012
360 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
361 EAR INFECTION 31 0.0012
362 FOOT FRACTURE 22 0.0012
363 MICTURITION DISORDER 4 0.0012
364 TONSILLITIS 6 0.0011
365 PARTIAL SEIZURES 6 0.0011
366 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
367 FEEDING DISORDER 23 0.0011
368 HAEMORRHAGIC DIATHESIS 4 0.0011
369 NASOPHARYNGITIS 206 0.0011
370 LARYNGOSPASM 3 0.0011
371 ASPARTATE AMINOTRANSFERASE INCREASED 59 0.0011
372 FOOD INTOLERANCE 4 0.0011
373 DEHYDRATION 144 0.0011
374 BODY TEMPERATURE INCREASED 22 0.0011
375 LUNG CONSOLIDATION 3 0.0011
376 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
377 ELECTRIC SHOCK SENSATION 3 0.0011
378 ILLNESS 110 0.0011
379 CEREBRAL THROMBOSIS 3 0.0011
380 SNORING 4 0.0011
381 OXYGEN SATURATION ABNORMAL 3 0.0011
382 INJECTION SITE SCAR 3 0.0011
383 SLEEP APNOEA SYNDROME 20 0.0010
384 INCREASED APPETITE 20 0.0010
385 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
386 TRANSAMINASES INCREASED 23 0.0010
387 THROMBOTIC MICROANGIOPATHY 10 0.0010
388 CARDIOPULMONARY FAILURE 4 0.0010
389 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
390 GROWTH RETARDATION 3 0.0010
391 BACTERIAL INFECTION 19 0.0010
392 STAPHYLOCOCCAL SEPSIS 5 0.0010
393 ENCEPHALITIS 7 0.0010
394 HYPERTRANSAMINASAEMIA 7 0.0010
395 BRAIN HERNIATION 3 0.0010
396 ATYPICAL PNEUMONIA 3 0.0010
397 HEADACHE 627 0.0010
398 HYPERCAPNIA 3 0.0010
399 PETIT MAL EPILEPSY 5 0.0010
400 FEMORAL NECK FRACTURE 5 0.0010
401 INCREASED UPPER AIRWAY SECRETION 5 0.0010
402 SPINAL STENOSIS 4 0.0010
403 FAILURE TO THRIVE 5 0.0010
404 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
405 UPPER LIMB FRACTURE 19 0.0010
406 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
407 BLOOD URINE PRESENT 18 0.0009
408 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
409 MOBILITY DECREASED 68 0.0009
410 DYSPHAGIA 89 0.0009
411 FOOD POISONING 5 0.0009
412 ALANINE AMINOTRANSFERASE INCREASED 57 0.0009
413 SEIZURE 107 0.0009
414 MUSCLE TIGHTNESS 15 0.0009
415 LYMPHOCYTE COUNT INCREASED 3 0.0009
416 BLOOD CREATINE INCREASED 4 0.0009
417 BLOOD POTASSIUM DECREASED 27 0.0009
418 DEVICE DISLOCATION 39 0.0009
419 HEART RATE ABNORMAL 5 0.0009
420 MULTIPLE ALLERGIES 7 0.0009
421 INJECTION SITE EXTRAVASATION 11 0.0009
422 URINARY TRACT DISORDER 4 0.0009
423 ASTHENIA 331 0.0009
424 GRANULOCYTOPENIA 5 0.0009
425 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
426 GAIT INABILITY 29 0.0009
427 CAESAREAN SECTION 10 0.0009
428 HEART RATE INCREASED 85 0.0009
429 EPILEPSY 26 0.0008
430 PLATELET COUNT INCREASED 11 0.0008
431 VOMITING 394 0.0008
432 HYPOXIA 29 0.0008
433 FALL 273 0.0008
434 SEPSIS 91 0.0008
435 MUSCULOSKELETAL DISCOMFORT 14 0.0008
436 PALLOR 22 0.0008
437 CARDIAC DYSFUNCTION 3 0.0008
438 KETOACIDOSIS 6 0.0008
439 URINE OUTPUT DECREASED 7 0.0008
440 STATUS EPILEPTICUS 9 0.0008
441 HEAD DISCOMFORT 14 0.0008
442 ROAD TRAFFIC ACCIDENT 33 0.0008
443 HAEMATURIA 27 0.0008
444 HYPERTHERMIA 6 0.0008
445 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
446 ACIDOSIS 6 0.0008
447 SCREAMING 5 0.0008
448 ANAL INCONTINENCE 7 0.0008
449 HIP FRACTURE 25 0.0008
450 INFUSION SITE PAIN 10 0.0008
451 CONCUSSION 6 0.0008
452 SINUS TACHYCARDIA 11 0.0008
453 TRISMUS 4 0.0008
454 NECK PAIN 43 0.0008
455 PULMONARY HAEMORRHAGE 6 0.0008
456 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
457 VENOUS THROMBOSIS 3 0.0008
458 AFFECTIVE DISORDER 6 0.0008
459 RESPIRATORY ACIDOSIS 3 0.0008
460 IRON DEFICIENCY ANAEMIA 7 0.0008
461 MALAISE 332 0.0008
462 RENAL CYST 6 0.0008
463 AZOTAEMIA 3 0.0008
464 OVERWEIGHT 4 0.0007
465 DECREASED ACTIVITY 8 0.0007
466 RHINORRHOEA 47 0.0007
467 UNDERDOSE 53 0.0007
468 SPINAL COMPRESSION FRACTURE 6 0.0007
469 PHARYNGITIS 9 0.0007
470 RESPIRATION ABNORMAL 5 0.0007
471 PRODUCT DOSE OMISSION 47 0.0007
472 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
473 ANGIOPATHY 4 0.0007
474 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
475 BRAIN OEDEMA 9 0.0007
476 BODY TEMPERATURE DECREASED 7 0.0007
477 MUSCLE ATROPHY 9 0.0007
478 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
479 PRODUCT DISPENSING ISSUE 3 0.0007
480 THERAPY CESSATION 36 0.0007
481 TACHYCARDIA 62 0.0007
482 PYELONEPHRITIS 6 0.0007
483 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
484 URINARY RETENTION 23 0.0007
485 ABORTION 2 0.0007
486 SPINAL PAIN 8 0.0007
487 MIGRAINE 65 0.0007
488 GINGIVAL SWELLING 3 0.0007
489 CARDIOMYOPATHY 10 0.0007
490 WHEELCHAIR USER 3 0.0007
491 COUGH 189 0.0007
492 PRODUCTIVE COUGH 32 0.0007
493 HYDRONEPHROSIS 5 0.0007
494 GENERAL SYMPTOM 5 0.0007
495 LIMB INJURY 18 0.0007
496 URINE ABNORMALITY 3 0.0007
497 PERIPHERAL COLDNESS 9 0.0007
498 PERICARDITIS 11 0.0007
499 MUSCLE TWITCHING 15 0.0007
500 UROSEPSIS 6 0.0006
501 NERVE COMPRESSION 6 0.0006
502 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
503 IRRITABILITY 39 0.0006
504 SKIN LACERATION 7 0.0006
505 OESOPHAGITIS 7 0.0006
506 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
507 OROPHARYNGEAL PAIN 59 0.0006
508 SKIN ABRASION 3 0.0006
509 HAEMATEMESIS 16 0.0006
510 RESPIRATORY TRACT CONGESTION 10 0.0006
511 INFECTION 91 0.0006
512 HYPOVOLAEMIC SHOCK 3 0.0006
513 HYPOPHAGIA 16 0.0006
514 HYPOKINESIA 9 0.0006
515 UNRESPONSIVE TO STIMULI 16 0.0006
516 FRUSTRATION TOLERANCE DECREASED 5 0.0006
517 DYSSTASIA 18 0.0006
518 HEPATIC ENZYME INCREASED 42 0.0006
519 BLOOD POTASSIUM INCREASED 10 0.0006
520 LUNG DISORDER 30 0.0006
521 GASTRIC HAEMORRHAGE 7 0.0006
522 ESCHERICHIA INFECTION 5 0.0006
523 PULMONARY CONGESTION 8 0.0006
524 LIVER FUNCTION TEST INCREASED 13 0.0006
525 INFLAMMATORY MARKER INCREASED 3 0.0006
526 BLADDER DISORDER 6 0.0006
527 POOR QUALITY SLEEP 13 0.0006
528 CARDIAC FAILURE ACUTE 4 0.0006
529 ERYSIPELAS 3 0.0006
530 METABOLIC ACIDOSIS 19 0.0006
531 KLEBSIELLA INFECTION 3 0.0006
532 HYPERSOMNIA 17 0.0006
533 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
534 CHOLECYSTITIS 7 0.0006
535 EYE MOVEMENT DISORDER 4 0.0006
536 MUSCULOSKELETAL CHEST PAIN 9 0.0006
537 SKIN NECROSIS 3 0.0006
538 LUNG INFILTRATION 5 0.0006
539 GENERALISED OEDEMA 7 0.0006
540 NYSTAGMUS 3 0.0006
541 HAND FRACTURE 4 0.0006
542 RESPIRATORY RATE INCREASED 5 0.0006
543 JOINT INJURY 12 0.0006
544 COMPRESSION FRACTURE 3 0.0006
545 SUBDURAL HAEMATOMA 8 0.0006
546 HAEMOLYTIC ANAEMIA 5 0.0006
547 INJECTION SITE DISCHARGE 3 0.0006
548 SEPTIC SHOCK 24 0.0006
549 CRYING 20 0.0005
550 FAECES SOFT 4 0.0005
551 MOUTH HAEMORRHAGE 4 0.0005
552 BLINDNESS TRANSIENT 4 0.0005
553 AMYLASE INCREASED 2 0.0005
554 LEUKAEMIA 5 0.0005
555 GENERAL PHYSICAL HEALTH DETERIORATION 61 0.0005
556 BOWEL MOVEMENT IRREGULARITY 4 0.0005
557 HAEMOLYSIS 4 0.0005
558 ELECTROLYTE IMBALANCE 6 0.0005
559 VASCULITIS 6 0.0005
560 TACHYPNOEA 7 0.0005
561 HYPOALBUMINAEMIA 4 0.0005
562 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
563 INFLAMMATORY BOWEL DISEASE 5 0.0005
564 HEPATOMEGALY 5 0.0005
565 BRADYKINESIA 3 0.0005
566 SENSORY DISTURBANCE 8 0.0005
567 TYPE 1 DIABETES MELLITUS 3 0.0005
568 HEPATITIS B 3 0.0005
569 RHINITIS 4 0.0005
570 ADRENAL INSUFFICIENCY 6 0.0005
571 MUSCLE DISORDER 4 0.0005
572 GASTROINTESTINAL DISORDER 44 0.0005
573 SUBARACHNOID HAEMORRHAGE 5 0.0005
574 BRADYCARDIA 26 0.0005
575 ENCEPHALOPATHY 12 0.0005
576 EAR DISCOMFORT 5 0.0005
577 HEART RATE DECREASED 17 0.0005
578 PHOTOPHOBIA 9 0.0005
579 WEIGHT FLUCTUATION 5 0.0005
580 WEIGHT INCREASED 107 0.0005
581 NASAL CONGESTION 28 0.0005
582 LABORATORY TEST ABNORMAL 14 0.0005
583 HYPOAESTHESIA 71 0.0005
584 HYPOGLYCAEMIA 23 0.0005
585 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
586 FEELING COLD 13 0.0005
587 PRODUCT CONTAINER ISSUE 4 0.0005
588 PANIC ATTACK 17 0.0005
589 MUSCLE STRAIN 4 0.0005
590 BRONCHITIS 34 0.0005
591 KIDNEY INFECTION 9 0.0005
592 URINARY TRACT INFECTION 78 0.0005
593 DYSGRAPHIA 3 0.0005
594 GRIP STRENGTH DECREASED 4 0.0005
595 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
596 FOOT DEFORMITY 5 0.0005
597 EYE HAEMORRHAGE 6 0.0004
598 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
599 MUSCULOSKELETAL STIFFNESS 39 0.0004
600 DEATH 383 0.0004
601 MITRAL VALVE INCOMPETENCE 5 0.0004
602 ACUTE HEPATIC FAILURE 6 0.0004
603 NEPHROTIC SYNDROME 3 0.0004
604 MYOCARDITIS 5 0.0004
605 DROOLING 3 0.0004
606 HYPOKALAEMIA 20 0.0004
607 BLOOD GLUCOSE ABNORMAL 8 0.0004
608 HEPATIC FUNCTION ABNORMAL 16 0.0004
609 CHOLELITHIASIS 14 0.0004
610 FLANK PAIN 4 0.0004
611 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
612 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
613 STAPHYLOCOCCAL INFECTION 14 0.0004
614 EATING DISORDER 9 0.0004
615 FRACTURE 8 0.0004
616 FEAR OF INJECTION 3 0.0004
617 CARDIOGENIC SHOCK 6 0.0004
618 CELLULITIS 21 0.0004
619 PAIN IN EXTREMITY 122 0.0004
620 PRODUCT DISPENSING ERROR 9 0.0004
621 VITAMIN D DEFICIENCY 4 0.0004
622 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
623 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
624 CONSTIPATION 89 0.0004
625 HYPOPHOSPHATAEMIA 3 0.0004
626 ARTHROPOD BITE 3 0.0004
627 PLATELET COUNT DECREASED 43 0.0004
628 CYST 5 0.0004
629 LETHARGY 23 0.0004
630 CHROMATURIA 9 0.0004
631 FATIGUE 310 0.0004
632 COLD SWEAT 7 0.0004
633 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
634 OSTEOPENIA 6 0.0004
635 HYPOTHERMIA 4 0.0004
636 DISCOMFORT 24 0.0004
637 SLUGGISHNESS 4 0.0004
638 LIPASE INCREASED 3 0.0004
639 EUPHORIC MOOD 4 0.0004
640 SINUSITIS 40 0.0004
641 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
642 PELVIC FRACTURE 3 0.0004
643 THROMBOCYTOPENIA 43 0.0004
644 TREATMENT NONCOMPLIANCE 21 0.0004
645 PETECHIAE 4 0.0004
646 GASTROINTESTINAL INFLAMMATION 3 0.0004
647 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
648 GASTRITIS 10 0.0004
649 INCONTINENCE 4 0.0004
650 BLOOD GLUCOSE DECREASED 18 0.0004
651 SENSORY LOSS 3 0.0004
652 BREAST CANCER METASTATIC 4 0.0004
653 SINUS CONGESTION 5 0.0004
654 BIPOLAR DISORDER 4 0.0004
655 IMPAIRED GASTRIC EMPTYING 5 0.0004
656 LIVER INJURY 9 0.0004
657 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
658 POLYURIA 3 0.0004
659 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
660 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
661 DIVERTICULITIS 10 0.0004
662 COAGULOPATHY 6 0.0004
663 HUNGER 5 0.0004
664 C-REACTIVE PROTEIN INCREASED 13 0.0004
665 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
666 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
667 SINUS DISORDER 7 0.0004
668 SEASONAL ALLERGY 5 0.0004
669 DYSURIA 13 0.0004
670 MICTURITION URGENCY 4 0.0003
671 INTERNAL HAEMORRHAGE 4 0.0003
672 PRODUCT ADMINISTRATION ERROR 7 0.0003
673 CONTUSION 33 0.0003
674 PRODUCT PREPARATION ERROR 7 0.0003
675 OSTEOPOROSIS 14 0.0003
676 PAIN 209 0.0003
677 CARDIAC FAILURE 27 0.0003
678 PULMONARY OEDEMA 15 0.0003
679 LEUKOCYTOSIS 6 0.0003
680 OSTEOMYELITIS 6 0.0003
681 OPTIC NEURITIS 3 0.0003
682 BRAIN NEOPLASM 3 0.0003
683 SPEECH DISORDER 17 0.0003
684 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
685 BALANCE DISORDER 28 0.0003
686 WEIGHT DECREASED 90 0.0003
687 ILEUS 4 0.0003
688 PARAESTHESIA 50 0.0003
689 INFUSION RELATED REACTION 21 0.0003
690 HEAD INJURY 10 0.0003
691 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
692 AFFECT LABILITY 3 0.0003
693 PRESCRIBED OVERDOSE 6 0.0003
694 DIZZINESS POSTURAL 3 0.0003
695 EAR PAIN 6 0.0003
696 DECREASED APPETITE 71 0.0003
697 VITREOUS FLOATERS 3 0.0003
698 MUSCLE SPASMS 56 0.0003
699 SHOCK 7 0.0003
700 URINARY INCONTINENCE 9 0.0003
701 ABNORMAL BEHAVIOUR 12 0.0003
702 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
703 BLOOD PRESSURE DECREASED 20 0.0003
704 SPINAL FRACTURE 6 0.0003
705 BLOOD UREA INCREASED 5 0.0003
706 NAUSEA 236 0.0003
707 PLEURAL EFFUSION 18 0.0003
708 PNEUMONITIS 8 0.0003
709 MOOD ALTERED 8 0.0003
710 INTESTINAL OBSTRUCTION 11 0.0003
711 GASTRIC DISORDER 10 0.0003
712 PRESYNCOPE 7 0.0003
713 GAIT DISTURBANCE 55 0.0003
714 CHEST PAIN 53 0.0003
715 AGITATION 21 0.0003
716 INJECTION SITE DISCOMFORT 3 0.0003
717 BLOOD TEST ABNORMAL 4 0.0003
718 ANXIETY 81 0.0003
719 RENAL PAIN 3 0.0003
720 DRUG ERUPTION 5 0.0003
721 INFLUENZA LIKE ILLNESS 23 0.0003
722 PULMONARY THROMBOSIS 3 0.0003
723 ARRHYTHMIA 13 0.0003
724 BONE DISORDER 5 0.0003
725 ABDOMINAL DISCOMFORT 46 0.0003
726 CHEST DISCOMFORT 28 0.0003
727 HEPATOTOXICITY 6 0.0003
728 DYSPNOEA 152 0.0003
729 HEPATIC STEATOSIS 5 0.0003
730 RASH PAPULAR 6 0.0003
731 SKIN INFECTION 3 0.0003
732 NEPHROPATHY TOXIC 3 0.0003
733 HYPONATRAEMIA 15 0.0003
734 DISEASE PROGRESSION 31 0.0003
735 HYPERKALAEMIA 9 0.0003
736 NERVOUS SYSTEM DISORDER 8 0.0003
737 FLUSHING 26 0.0003
738 HYPERTENSION 54 0.0003
739 EPISTAXIS 19 0.0003
740 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
741 HALLUCINATION, AUDITORY 4 0.0003
742 CYSTITIS 8 0.0003
743 OBESITY 4 0.0003
744 MUSCLE RIGIDITY 3 0.0003
745 WRIST FRACTURE 3 0.0003
746 DIABETIC KETOACIDOSIS 6 0.0002
747 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
748 MUSCULOSKELETAL PAIN 13 0.0002
749 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
750 TREMOR 41 0.0002
751 FLATULENCE 14 0.0002
752 BACK DISORDER 4 0.0002
753 THROAT IRRITATION 11 0.0002
754 ABDOMINAL PAIN 57 0.0002
755 IMPAIRED HEALING 8 0.0002
756 SPINAL OPERATION 3 0.0002
757 MULTIPLE FRACTURES 4 0.0002
758 VENTRICULAR TACHYCARDIA 4 0.0002
759 INJECTION SITE PAIN 74 0.0002
760 AGGRESSION 12 0.0002
761 TINNITUS 11 0.0002
762 CANDIDA INFECTION 4 0.0002
763 THROMBOSIS 19 0.0002
764 CARDIAC DISORDER 22 0.0002
765 INTRAOCULAR PRESSURE INCREASED 3 0.0002
766 RETCHING 5 0.0002
767 HEPATITIS 6 0.0002
768 ABDOMINAL PAIN UPPER 48 0.0002
769 HEPATIC FAILURE 7 0.0002
770 APHASIA 7 0.0002
771 DEVICE LEAKAGE 10 0.0002
772 FEELING HOT 14 0.0002
773 PANCREATITIS 12 0.0002
774 LIMB DISCOMFORT 7 0.0002
775 ISCHAEMIC STROKE 4 0.0002
776 HEART RATE IRREGULAR 5 0.0002
777 PELVIC PAIN 4 0.0002
778 SYNCOPE 22 0.0002
779 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
780 MOVEMENT DISORDER 7 0.0002
781 SKIN DISCOLOURATION 10 0.0002
782 PERICARDIAL EFFUSION 5 0.0002
783 APHONIA 3 0.0002
784 MASS 3 0.0002
785 WOUND 6 0.0002
786 BLOOD SODIUM DECREASED 4 0.0002
787 GASTRIC ULCER 4 0.0002
788 ANGER 7 0.0002
789 LOCALISED INFECTION 5 0.0002
790 MYALGIA 35 0.0002
791 CEREBRAL INFARCTION 5 0.0002
792 PSYCHOTIC DISORDER 6 0.0002
793 DIZZINESS 101 0.0002
794 RENAL INJURY 6 0.0002
795 RASH 88 0.0002
796 HAEMATOCRIT DECREASED 4 0.0002
797 INCORRECT DOSE ADMINISTERED 46 0.0002
798 BLOOD PRESSURE ABNORMAL 4 0.0002
799 ABDOMINAL DISTENSION 21 0.0002
800 DEEP VEIN THROMBOSIS 13 0.0002
801 NEUROPATHY PERIPHERAL 19 0.0002
802 ABORTION SPONTANEOUS 8 0.0002
803 SWELLING FACE 13 0.0002
804 HYPOTENSION 40 0.0002
805 HAEMATOCHEZIA 11 0.0002
806 DEVICE FAILURE 3 0.0002
807 HAEMOGLOBIN DECREASED 20 0.0002
808 RIB FRACTURE 4 0.0002
809 DIPLOPIA 5 0.0002
810 DRUG-INDUCED LIVER INJURY 6 0.0002
811 DEAFNESS 5 0.0002
812 DERMATITIS 4 0.0002
813 PULMONARY EMBOLISM 18 0.0002
814 COMA 9 0.0002
815 HYPERSENSITIVITY 35 0.0002
816 PREMATURE DELIVERY 3 0.0002
817 BLOOD BILIRUBIN INCREASED 5 0.0002
818 COLITIS 7 0.0002
819 FEELING ABNORMAL 44 0.0002
820 MANIA 3 0.0002
821 ANAPHYLACTIC REACTION 10 0.0002
822 VERTIGO 11 0.0002
823 ARTHROPATHY 10 0.0002
824 MEDICATION ERROR 10 0.0002
825 PANCREATITIS ACUTE 4 0.0002
826 FLUID RETENTION 9 0.0002
827 INJECTION SITE BRUISING 14 0.0002
828 DIARRHOEA 112 0.0002
829 EOSINOPHILIA 3 0.0002
830 CHILLS 20 0.0002
831 DEPRESSED MOOD 9 0.0002
832 ASCITES 5 0.0002
833 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
834 SOMNOLENCE 34 0.0002
835 THIRST 3 0.0002
836 ARTHRALGIA 69 0.0002
837 DRUG EFFECT INCOMPLETE 6 0.0002
838 RESTLESSNESS 6 0.0002
839 ANAEMIA 31 0.0002
840 PERIPHERAL SWELLING 25 0.0002
841 EMOTIONAL DISORDER 5 0.0002
842 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
843 MENTAL DISORDER 7 0.0002
844 MIDDLE INSOMNIA 3 0.0002
845 SWELLING 15 0.0002
846 ABDOMINAL PAIN LOWER 4 0.0002
847 LIVER DISORDER 7 0.0002
848 BURNING SENSATION 11 0.0002
849 ACUTE KIDNEY INJURY 24 0.0002
850 LOSS OF CONSCIOUSNESS 20 0.0002
851 HYPERHIDROSIS 20 0.0002
852 ERUCTATION 3 0.0002
853 INFLAMMATION 8 0.0002
854 SKIN ULCER 4 0.0002
855 DYSPHONIA 9 0.0002
856 HAEMORRHOIDS 3 0.0002
857 BLOOD CREATININE INCREASED 10 0.0002
858 HAEMORRHAGE 16 0.0002
859 MENORRHAGIA 3 0.0002
860 DRUG DOSE OMISSION 25 0.0002
861 LIP SWELLING 5 0.0001
862 COGNITIVE DISORDER 7 0.0001
863 FEAR 4 0.0001
864 PRODUCT PHYSICAL ISSUE 3 0.0001
865 INTENTIONAL SELF-INJURY 3 0.0001
866 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
867 INJURY ASSOCIATED WITH DEVICE 3 0.0001
868 DIABETES MELLITUS 11 0.0001
869 RASH MACULAR 5 0.0001
870 DEVICE MALFUNCTION 10 0.0001
871 SLEEP DISORDER 10 0.0001
872 PAIN IN JAW 4 0.0001
873 DEPRESSION 32 0.0001
874 IRRITABLE BOWEL SYNDROME 3 0.0001
875 RED BLOOD CELL COUNT DECREASED 4 0.0001
876 CEREBRAL HAEMORRHAGE 5 0.0001
877 HERPES ZOSTER 8 0.0001
878 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
879 PRODUCT PRESCRIBING ISSUE 3 0.0001
880 NEEDLE ISSUE 4 0.0001
881 BLOOD PRESSURE INCREASED 21 0.0001
882 ACCIDENTAL OVERDOSE 5 0.0001
883 MELAENA 3 0.0001
884 INSOMNIA 36 0.0001
885 RASH MACULO-PAPULAR 3 0.0001
886 DYSARTHRIA 5 0.0001
887 ASTHMA 15 0.0001
888 SUICIDE ATTEMPT 8 0.0001
889 PRODUCT AVAILABILITY ISSUE 3 0.0001
890 SUICIDAL IDEATION 12 0.0001
891 MEMORY IMPAIRMENT 18 0.0001
892 RENAL IMPAIRMENT 11 0.0001
893 RENAL DISORDER 6 0.0001
894 SWOLLEN TONGUE 4 0.0001
895 INJURY 9 0.0001
896 DRUG INEFFECTIVE 168 0.0001
897 BLISTER 7 0.0001
898 ALOPECIA 24 0.0001
899 LEUKOPENIA 6 0.0001
900 RHABDOMYOLYSIS 5 0.0001
901 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
902 CARDIOVASCULAR DISORDER 3 0.0001
903 WHEEZING 7 0.0001
904 ERYTHEMA 24 0.0001
905 HYPOACUSIS 5 0.0001
906 RASH GENERALISED 3 0.0001
907 ILL-DEFINED DISORDER 7 0.0001
908 OEDEMA PERIPHERAL 14 0.0001
909 INJECTION SITE HAEMORRHAGE 9 0.0001
910 BREAST CANCER FEMALE 3 0.0001
911 THERAPY INTERRUPTED 8 0.0001
912 FREQUENT BOWEL MOVEMENTS 3 0.0001
913 RASH PRURITIC 6 0.0001
914 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
915 INJECTION SITE MASS 4 0.0001
916 HAEMOPTYSIS 3 0.0001
917 OCULAR HYPERAEMIA 5 0.0001
918 DRUG INTOLERANCE 10 0.0001
919 PRODUCT STORAGE ERROR 9 0.0001
920 ATRIAL FIBRILLATION 10 0.0001
921 SURGERY 6 0.0001
922 OVERDOSE 22 0.0001
923 VISION BLURRED 14 0.0001
924 URTICARIA 17 0.0001
925 CARDIAC FAILURE CONGESTIVE 8 0.0001
926 LACRIMATION INCREASED 3 0.0001
927 DEVICE BREAKAGE 4 0.0001
928 DYSKINESIA 4 0.0001
929 NEUTROPHIL COUNT DECREASED 4 0.0001
930 DRUG ADMINISTRATION ERROR 3 0.0001
931 BONE DENSITY DECREASED 3 0.0001
932 DRUG EFFECT DECREASED 5 0.0001
933 DISTURBANCE IN ATTENTION 5 0.0001
934 OEDEMA 5 0.0001
935 MYOCARDIAL INFARCTION 16 0.0001
936 DYSPEPSIA 9 0.0001
937 EMOTIONAL DISTRESS 11 0.0001
938 RENAL FAILURE 12 0.0001
939 FUNGAL INFECTION 3 0.0001
940 SKIN DISORDER 3 0.0001
941 COLITIS ULCERATIVE 4 0.0001
942 ARTHRITIS 7 0.0001
943 PRURITUS 34 0.0001
944 PALPITATIONS 10 0.0001
945 OFF LABEL USE 74 0.0001
946 RASH ERYTHEMATOUS 4 0.0001
947 MULTIPLE SCLEROSIS 4 0.0001
948 EYE SWELLING 3 0.0001
949 CONFUSIONAL STATE 13 0.0001
950 INJECTION SITE SWELLING 6 0.0001
951 DISORIENTATION 3 0.0001
952 JOINT SWELLING 9 0.0001
953 EXTRA DOSE ADMINISTERED 3 0.0001
954 BLINDNESS 3 0.0001
955 POLLAKIURIA 3 0.0001
956 CEREBROVASCULAR ACCIDENT 12 0.0001
957 RECTAL HAEMORRHAGE 3 0.0001
958 BLOOD GLUCOSE INCREASED 13 0.0001
959 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
960 BONE PAIN 4 0.0001
961 ACUTE MYOCARDIAL INFARCTION 2 0.0001
962 ANGIOEDEMA 3 0.0001
963 CATARACT 4 0.0001
964 ACNE 5 0.0001
965 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
966 NEOPLASM MALIGNANT 4 0.0001
967 NEUTROPENIA 8 0.0001
968 INJECTION SITE REACTION 4 0.0001
969 NERVOUSNESS 3 0.0001
970 ECZEMA 3 0.0001
971 VISUAL IMPAIRMENT 7 0.0001
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
974 DYSGEUSIA 4 0.0001
975 CHRONIC KIDNEY DISEASE 4 0.0001
976 THERAPEUTIC RESPONSE DECREASED 3 0.0000
977 DRY MOUTH 4 0.0000
978 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
979 TREATMENT FAILURE 4 0.0000
980 HOSPITALISATION 7 0.0000
981 BREAST CANCER 4 0.0000
982 TOXICITY TO VARIOUS AGENTS 7 0.0000
983 HALLUCINATION 3 0.0000
984 CONDITION AGGRAVATED 12 0.0000
985 AMNESIA 2 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 DRUG INTERACTION 4 0.0000
988 INJECTION SITE ERYTHEMA 3 0.0000
989 ADVERSE DRUG REACTION 2 0.0000
990 PRODUCT QUALITY ISSUE 3 0.0000